Abstract: An apparatus for an alpha trim adjustment includes a phase delay circuit that creates a phase delay for a gate signal for a switching cycle. The gate signal is for a phase of a three-phase, phase shifted alternating current (“AC”) input of a multi-pulse motor drive powering a direct current (“DC”) motor. The apparatus includes an alpha trim circuit that modifies the phase delay with an alpha trim adjustment to create an adjusted phase delay for the switching cycle, a delay application circuit that applies the adjusted phase delay to the gate signal.

Abstract: An apparatus for an alpha trim adjustment includes a phase delay circuit that creates a phase delay for a gate signal for a switching cycle. The gate signal is for a phase of a three-phase, phase shifted alternating current (“AC”) input of a multi-pulse motor drive powering a direct current (“DC”) motor. The apparatus includes an alpha trim circuit that modifies the phase delay with an alpha trim adjustment to create an adjusted phase delay for the switching cycle, a delay application circuit that applies the adjusted phase delay to the gate signal.

Abstract: The present invention relates to a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.

Abstract: The disclosure provides systems, devices, and associated methods for mitigating traumatic brain injury, injury to an ocular structure, or injury to the inner ear of a subject by applying pressure to one or more neck veins before and during an injurious event.

Abstract: A dental guard including a generally u-shaped band having a curved central portion and a pair of opposite aft ends, each of the aft ends of the band including a laterally extending cylindrical protrusion; and a pair of bite pad assemblies adjustably mountable onto the opposite aft ends of the band. Each of the bite pad assemblies includes a longitudinal channel configured for receiving one of the aft ends of the band for adjusting the location of the bite pad assembly on the band to adjust the length of the dental guard. Each of the bite pad assemblies also includes an elongate slot defined in a sidewall of the bite pad assembly adjacent to and open to the channel, the slot being configured to receive the laterally extending cylindrical protrusion of the aft end of the band and the slot including a plurality of spaced apart receivers for fixedly but releasably receiving the protrusion to enable adjustable positioning of the bite pad assembly relative to the aft end.

Abstract: The present invention relates to a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.

Abstract: A pocket for a golf bag includes a main body defining a storage compartment. The pocket includes a first attachment mechanism movable between an attached state attaching the main body to a first attachment location of the golf bag and a detached state allowing the main body to be separated from the first attachment location. The pocket also includes a second attachment mechanism movable between an attached state attaching the main body to a second attachment location of the golf bag and a detached state allowing the main body to be separated from the second attachment location. The pocket includes a carry mechanism operable to allow the main body to be carried separately from the golf bag when the first attachment mechanism is in the detached state and the second attachment mechanisms is in the detached state.

Abstract: The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.

Abstract: Disclosed is a water-proof and dust-proof membrane assembly and applications thereof. The water-proof and dust-proof membrane assembly comprises a body and a supporting member. The body is of membrane and has a first surface, a second surface, and an asymmetric porous structure formed between the first surface and the second surface of the body. The asymmetric porous structure has a thickness ranging between 1 ?m and 1000 ?m, a first volumetric porosity ranging between 5% and 99%. The asymmetric porous structure has plural pores, and each pore has a pore diameter between 0.01 ?m and 15 ?m. The supporting member is of a polymeric material and has a first contacting surface, a second contacting surface, and a second volumetric porosity which is greater than the first volumetric porosity. The first contacting surface of the supporting member is adhered to the first surface of the body.

Abstract: Devices and methods to compress sensor data are generally described herein. An exemplary wearable device to compress sensor data may include a sensor including circuitry to sense sensor data, and a communication circuit to receive, from a remote device, a detected link quality of a low-power communication channel used to communicate with the remote device. The communication circuit further to transmit compressed data to a remote device over the low power communication channel. The wearable device may further include a compressible sensor data module to apply a compression algorithm to compress received sensor data based on the detected link quality to provide the compressed sensor data.

Abstract: Devices and methods to compress sensor data are generally described herein. An exemplary wearable device to compress sensor data may include a sensor including circuitry to sense sensor data, and a communication circuit to receive, from a remote device, a detected link quality of a low-power communication channel used to communicate with the remote device. The communication circuit further to transmit compressed data to a remote device over the low power communication channel. The wearable device may further include a compressible sensor data module to apply a compression algorithm to compress received sensor data based on the detected link quality to provide the compressed sensor data.

Abstract: The present invention relates to a pharmaceutical aqueous formulation comprising -(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. Such a formulation is particularly suitable for intravenous or parenteral administration to a patient.

Abstract: An accessory bag for a main bag is provided and may include a main body extending along a longitudinal axis between a first end and a second end. The main body may be movable between a collapsed state having the first end disposed proximate to the second end and an expanded state having the first end separated from the second end. The accessory bag may further include an attachment device associated with one of the first end and the second end that selectively attaches the main body to the main bag.

Abstract: Techniques for optimizing wearable device settings using machine learning are described. A mobile device may receive, from a wearable device (such as a wristwatch), sensor data corresponding to a reaction of a user wearing the wearable device to an output modality produced by the wearable device. The mobile device may solicit user feedback for the output modality produced by the wearable device. The mobile device may receive, via a sensor set, user feedback data corresponding to a user feedback for the output modality. The mobile device may upload the sensor data and the user feedback data to a cloud-based application. The mobile device may receive a knowledge package, including a classification algorithm trained using the sensor data and the user feedback data, from the cloud-based application. Finally, the mobile device may send the knowledge package to the wearable device.

Abstract: A pocket for a golf bag includes a main body defining a storage compartment. The pocket includes a first attachment mechanism movable between an attached state attaching the main body to a first attachment location of the golf bag and a detached state allowing the main body to be separated from the first attachment location. The pocket also includes a second attachment mechanism movable between an attached state attaching the main body to a second attachment location of the golf bag and a detached state allowing the main body to be separated from the second attachment location. The pocket includes a carry mechanism operable to allow the main body to be carried separately from the golf bag when the first attachment mechanism is in the detached state and the second attachment mechanisms is in the detached state.

Abstract: An accessory bag for a main bag is provided and may include a main body extending along a longitudinal axis between a first end and a second end. The main body may be movable between a collapsed state having the first end disposed proximate to the second end and an expanded state having the first end separated from the second end. The accessory bag may further include an attachment device associated with one of the first end and the second end that selectively attaches the main body to the main bag.